Prominent scientist in the area of molecular imaging and radionuclide treatment of these rare tumours
Prof Dr Alexander Haug
Alexander Haug is an Associate Professor of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine and Deputy Head of the Division of Nuclear Medicine. He currently works at the University Clinic General Hospital Vienna (AKH) looking after patients from the entire field of nuclear medicine, especially patients with thyroid diseases, but also neuroendocrine tumours and prostate cancer.
His research focuses are the use of theragnostic, particularly in neuroendocrine tumours and prostate cancer, PET-imaging of specific biomarkers such as the CXCR4 receptor with a prognostic or predictive impact in cancer, and machine learning approaches for improving the impact of imaging.
Professor Doctor Haug started his researches at the Ludwig Maximilian’s University in Munich and continue his specialist training at the Großhadern University Hospital, also in Munich, where from 2009 he was responsible for the thyroid outpatient department and the therapy ward as a senior physician.
In 2013 he debuted as deputy head of the clinical department for nuclear medicine at the University General Hospital Vienna, being head of two of the largest nuclear medicine therapy wards in Europe. During this period, the doctor acquired extensive specialist knowledge in the area, even with rare and complex diseases.
Due to his specialty and research work, the doctor, along with his team, was able to introduce a new therapy with 177 Lu-PSMA for patients with advanced prostate cancer in Vienna.
Dr. Haug has a track record in oncologic hybrid imaging. He is PI of several studies, mainly dealing with radionuclide-therapy and oncologic imaging with PET/CT and PET/MRI. He currently supervises 4 PhD students and has successfully supervised 7 “Dr. med.” projects.
Furthermore, Professor Doctor Haug is head of the Christian Doppler Laboratory for Applied Metabolomics, head of the Therapy Committee of the Austrian Society for Nuclear Medicine and Molecular Imaging, as well as a member of the “Nuclides in Nuclear Therapy”, a working group of the Radiation Protection in Medicine Committee of the Radiation Protection Commission, Federal Office for Radiation Protection.
As an author, he has published more than 120 scientific articles in international journals and has given over 100 specialist lectures at national and international congresses.
